Skip to main content

CORRECTION article

Front. Immunol., 13 December 2022
Sec. Alloimmunity and Transplantation
Volume 13 - 2022 | https://doi.org/10.3389/fimmu.2022.1108216

Corrigendum: Bone marrow mesenchymal stem cells in premature ovarian failure: Mechanisms and prospects

This article is a correction to:

  1. Present and Future: Crosstalks Between Polycystic Ovary Syndrome and Gut Metabolites Relating to Gut Microbiota

    1. Read original article
Yanjing HuangYanjing Huang1Mengdi ZhuMengdi Zhu1Zhuo LiuZhuo Liu1Runan HuRunan Hu1Fan LiFan Li1Yufan SongYufan Song1Yuli GengYuli Geng1Wenwen MaWenwen Ma2Kunkun Song*Kunkun Song2*Mingmin Zhang*Mingmin Zhang2*
  • 1Institute of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
  • 2Department of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

A Corrigendum on
Bone marrow mesenchymal stem cells in premature ovarian failure: Mechanisms and prospects.

Huang Y, Zhu M, Liu Z, Hu R, Li F, Song Y, Geng Y, Ma W, Song K and Zhang M (2022)  13:997808. doi: 10.3389/fimmu.2022.997808

In the published article, there was an error in the Funding statement. It was incorrectly stated that “This work was supported by the National Natural Science Foundation of China, No. 8190141809” instead of “This work was supported by the National Natural Science Foundation of China, No. 81904008.” The correct Funding statement appears below.

Funding

This work was supported by the National Natural Science Foundation of China, No. 81904008.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: premature ovarian failure, mesenchymal stem cells, ovary, ovarian function, bone marrow

Citation: Huang Y, Zhu M, Liu Z, Hu R, Li F, Song Y, Geng Y, Ma W, Song K and Zhang M (2022) Corrigendum: Bone marrow mesenchymal stem cells in premature ovarian failure: Mechanisms and prospects. Front. Immunol. 13:1108216. doi: 10.3389/fimmu.2022.1108216

Received: 25 November 2022; Accepted: 02 December 2022;
Published: 13 December 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Huang, Zhu, Liu, Hu, Li, Song, Geng, Ma, Song and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Mingmin Zhang, mmzhangeins@163.com; Kunkun Song, 1393137368@qq.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.